MARKET

KAPA

KAPA

KAIROS PHARMA LTD
AMEX
0.6201
-0.0199
-3.11%
Closed 19:45 05/13 EDT
OPEN
0.6208
PREV CLOSE
0.6400
HIGH
0.6400
LOW
0.6043
VOLUME
104.31K
TURNOVER
0
52 WEEK HIGH
4.000
52 WEEK LOW
0.5802
MARKET CAP
10.59M
P/E (TTM)
-2.7055
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KAPA last week (0505-0509)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 1d ago
Weekly Report: what happened at KAPA last week (0428-0502)?
Weekly Report · 05/05 12:37
Weekly Report: what happened at KAPA last week (0421-0425)?
Weekly Report · 04/28 12:52
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 04/25 21:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 04/25 12:09
Kairos Pharma Issues Letter To Stockholders; Updates Two Ongoing Clinical Trials For ENV105 For Patients With Prostate Cancer And KROS101 For Cancer Treatment
Benzinga · 04/24 12:05
Kairos Pharma files to sell 16.29M shares of common stock for holders
TipRanks · 04/22 10:10
More
About KAPA
More
Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company. It is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression in cancer. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Its lead candidate, ENV105, is an antibody that targets CD105, a protein identified as a key driver of resistance to various cancer treatments. ENV105 focused on reversing drug resistance by targeting CD105 and restoring the effectiveness of standard therapies across multiple cancer types. ENV105 is in a Phase II clinical trial for castrate-resistant prostate cancer and a Phase I trial for lung cancer, with the trials aimed at addressing unmet medical needs. Its portfolio includes various drug therapies consisting of peptide and small molecule cancer immunotherapeutics KROS 101, 102, 201, 301, and 401 and therapeutic agents ENV 105 and 205.
Recently
Symbol
Price
%Change

Webull offers Kairos Pharma Ltd stock information, including AMEX: KAPA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KAPA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KAPA stock methods without spending real money on the virtual paper trading platform.